
The Vox Markets Podcast
Vox Markets is revolutionising the way companies engage with all classes of shareholders. Listen here to interviews with company executives and sell-side analysts and fund managers discuss their investment insights.
Latest episodes

Jan 31, 2025 • 9min
2029: Q&A with Paul Barrett from Rome Resources
Watch on YouTube
More drilling news from Rome Resources, this time at Kalayi. Paul Barrett joins us to explain the significance of the latest results, what it all means, and what will happen next

Jan 29, 2025 • 12min
2028: Q&A with hVIVO CEO, Mo Khan
Exciting times for the company as we sit down with Mo to discuss a record-breaking FY24, the game-changing acquisition of two clinical research units from CRS, and the strategic vision driving future growth. Mo shares insights on the synergies behind the CRS deal, the growing order book, and the evolving £40m pipeline of opportunities. Plus, we explore what’s next for the company’s M&A strategy. Don’t miss this deep dive into a company on the rise!”

Jan 28, 2025 • 19min
2027: Q&A with Eleco CEO Jonathan Hunter and CFO Neil Pritchard
Watch on YouTube
Following today’s positive FY'24 trading update, CEO Jonathan Hunter and CFO Neil Pritchard of Eleco #ELCO kindly take me through the:
00:00 Current demand picture & recent client wins for Eleco’s Buildtech software.
05:20 Financial highlights
10:10 Strategic rationale & integration of Jan’s €8.4m acquisition of PMI Software
13:50 Outlook for 2025 and beyond.
Disclosure: I own shares in Eleco, who is also a Vox Markets client

Jan 28, 2025 • 20min
2026: Q&A with Lords Group Trading CEO Shanker Patel & CFO Stuart Kilpatrick
Watch on YouTube
Following today’s resilient FY'24 trading update, CEO Shanker Patel & CFO Stuart Kilpatrick of Lords Group Trading - a specialist UK builders merchant & heating/plumbing products distributor – take me through the :
State of the UK building products market & timing of recovery.
Financial highlights & outlook for 2025.
Why investors should remain optimistic.

Jan 27, 2025 • 7min
2025: Addressing the Rising Threat of Whooping Cough
Watch on YouTube
In an exclusive interview, hVIVO CEO Mo Khan discusses the company’s latest milestone—a world-first pivotal Phase 3 human challenge trial for a whooping cough (pertussis) vaccine candidate. Mo delves into why ILiAD is leading this groundbreaking initiative, the trial’s key objectives, and its significance for hVIVO’s expanding portfolio. He also provides insight into the increasing global burden of pertussis and hVIVO’s readiness to conduct bacterial challenge trials at its state-of-the-art Canary Wharf facility.

Jan 23, 2025 • 1h 2min
2024: Small-Cap Investing with Paul Hill & Paul Scott
Watch on YouTube
In this week’s smallcap investing show, UK analyst & stock markets commentator Paul Scott & I discussed our latest thoughts on the following:
00:00 Are animal spirits returning to the equity markets?
02:30 Which sectors might benefit from UK government deregulation?
04:50 Serica Energy
09:20 Watkin Jones
10:10 abrdn
13:25 Capital (Drilling) Ltd
16:45 Beeks Financial
20:15 Cordel Group
25:50 Windar Photonics
29:25 Colefax
31:50 Zotefoams
33:25 Spectra Systems
35:35 James Latham
37:25 Epwin Group
39:10 Card Factory
40:50 JD Sports
44:00 Creo Medical
48:55 Feedback Medical
51:35 LBG Media
55:20 System1
58:05 1Spatial
Due to a diary clash, the next episode is in 2 weeks time (Friday 7th Feb)
Finally, if anyone or any company would like to sponsor this Smallcap Investing series (re naming rights), then please feel free to contact me here or via my email paulhill@pmhcapital.com.
#SQZ #WJG #ABDN #CAPD #BKS #CRDL #WPHO #CFX #ZTF #SPSY #LTHM #EPWN #CARD #JD. #CREO #CREO #FDBK #LBG #SYS1 #SPA

Jan 21, 2025 • 9min
2023: Rome Resources Announces Results from Latest Drilling at Mont Agoma
Watch on YouTube
Rome Resources has released assay results from two holes drilled at its Mont Agoma tin project in the Democratic Republic of Congo. The results support the company's geological interpretation of Mont Agoma, and the grades look world class. Chief executive Paul Barrett joints us to explain.

Jan 21, 2025 • 7min
2022: Q&A with hVIVO CEO, Mo Khan
Watch on YouTube
hVIVO has secured a £2.7 million contract for its hLAB division to serve as the sole virology lab for a global Phase 2 influenza drug study involving 5,000 participants. This milestone marks hVIVO's largest standalone lab services contract, leveraging its expanded Canary Wharf facility.

Jan 20, 2025 • 1h 7min
2021: The Exchange with Dr Paul Jourdan of Amati Global Investors
Watch on YouTube
In this investing masterclass, accomplished UK fund manager Paul Jourdan of Amati Global Investors takes me through his view of the markets and latest thoughts on 19 stock ideas, including:
00:00 Outlook for 2025
08:00 Diaceutics
11:30 Creo Medical
16:30 IXICO
18:25 UK building products sector & Brickability Group
19:55 Tracsis
23:50 Cordel Group
25:55 essensys
29:20 Water Intelligence
30:50 Private medicine & Spire Healthcare Group plc
32:40 Windar Photonics A/S
34:50 Solid State
39:40 EnSilica
42:35 SRT Marine Systems plc
45:30 Ashtead Technology
48:35 Serica Energy plc
55:40 Greatland Gold
58:40 Hochschild Mining
1:01:45 STV Group plc
1:02:20 Two favourite stock ideas for 2025 – Feedback & Alpha Group International.
Lastly, if anyone or any company would like to sponsor the Show (re naming rights), then please feel free to contact me here or via my email address paulhill@pmhcapital.com.

Jan 17, 2025 • 1h 12min
2020: Small-Cap Investing with Paul Hill & Paul Scott
Watch on YouTube
In this week’s smallcap investing show, UK analyst & stock markets commentator Paul Scott & I discussed our latest thoughts on the following:
00:00 Bond market relief as inflation falls
03:05 IG Design Group
11:45 Card Factory
15:45 JD Sports
19:50 Sosander
23:15 FD Technologies
25:55 Everyman Media
29:55 Facilities by ADF
34:55 UK housebuilders: Vistry, Persimmon Homes, Gleeson Homes & Taylor Wimpey
41:50 SRT Marine Systems
45:10 Fonix
47:30 Construction contractors – Galliford Try and Costain
52:30 Eagle Eye
56:25 Asset managers – Polar Capital, Premier Miton, Liontrust Asset Management
64:15 Spire Healthcare
67:45 PayPoint